Cardiolipin liposomes: A novel flow reagent for detection of anticardiolipin antibodies

Samuel Jay Pirruccello, S. K. Brusnahan

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

The association of autoantibodies with specificity for phospholipids and an increased risk for thromboembolic phenomena has received considerable recent clinical attention. These autoantibodies have been reported in patients with defined autoimmune disorders as well as in patients with no other obvious autoimmune disease symptoms other than isolated or recurrent thromboembolic disease. A significant component of this autoimmune response appears to be related to cardiolipin‐directed antibodies. Most studies reported to date have used either an enzyme immunoassay or a radioimmunoassay for detection and quantitation of antiphospholipid antibodies. We have developed a novel flow cytometric assay for detection of anticardiolipin antibodies. The assay, by analogy to polystyrene microsphere assay, utilizes cardiolipin liposomes as solid‐phase microspheres for antigen presentation. In comparison to enzyme‐linked immunosorbent assay, the flow assay shows similar sensitivity by serum titration, has immunoglobulin class specificity, and is semiquantitative as currently designed. The flow assay is relatively easy to perform and should allow detection of other antiphospholipid specificities with tailoring of the phospholipid makeup of the liposomes.

Original languageEnglish (US)
Pages (from-to)236-240
Number of pages5
JournalJournal of Clinical Laboratory Analysis
Volume4
Issue number3
DOIs
StatePublished - 1990

Fingerprint

Anticardiolipin Antibodies
Cardiolipins
Microspheres
Liposomes
Autoantibodies
Assays
Phospholipids
Immunosorbents
Antiphospholipid Antibodies
Immunoglobulin Isotypes
Polystyrenes
Antigen Presentation
Autoimmunity
Immunoenzyme Techniques
Autoimmune Diseases
Radioimmunoassay
Antibodies
Serum
Titration
Association reactions

Keywords

  • Systemic lupus erythematosus
  • anticardiolipin antibodies
  • flow cytometry
  • thrombosis

ASJC Scopus subject areas

  • Immunology and Allergy
  • Hematology
  • Public Health, Environmental and Occupational Health
  • Clinical Biochemistry
  • Medical Laboratory Technology
  • Biochemistry, medical
  • Microbiology (medical)

Cite this

Cardiolipin liposomes : A novel flow reagent for detection of anticardiolipin antibodies. / Pirruccello, Samuel Jay; Brusnahan, S. K.

In: Journal of Clinical Laboratory Analysis, Vol. 4, No. 3, 1990, p. 236-240.

Research output: Contribution to journalArticle

@article{ae36567b7c1f4061bca3d772cfda1cce,
title = "Cardiolipin liposomes: A novel flow reagent for detection of anticardiolipin antibodies",
abstract = "The association of autoantibodies with specificity for phospholipids and an increased risk for thromboembolic phenomena has received considerable recent clinical attention. These autoantibodies have been reported in patients with defined autoimmune disorders as well as in patients with no other obvious autoimmune disease symptoms other than isolated or recurrent thromboembolic disease. A significant component of this autoimmune response appears to be related to cardiolipin‐directed antibodies. Most studies reported to date have used either an enzyme immunoassay or a radioimmunoassay for detection and quantitation of antiphospholipid antibodies. We have developed a novel flow cytometric assay for detection of anticardiolipin antibodies. The assay, by analogy to polystyrene microsphere assay, utilizes cardiolipin liposomes as solid‐phase microspheres for antigen presentation. In comparison to enzyme‐linked immunosorbent assay, the flow assay shows similar sensitivity by serum titration, has immunoglobulin class specificity, and is semiquantitative as currently designed. The flow assay is relatively easy to perform and should allow detection of other antiphospholipid specificities with tailoring of the phospholipid makeup of the liposomes.",
keywords = "Systemic lupus erythematosus, anticardiolipin antibodies, flow cytometry, thrombosis",
author = "Pirruccello, {Samuel Jay} and Brusnahan, {S. K.}",
year = "1990",
doi = "10.1002/jcla.1860040317",
language = "English (US)",
volume = "4",
pages = "236--240",
journal = "Journal of Clinical Laboratory Analysis",
issn = "0887-8013",
publisher = "Wiley-Liss Inc.",
number = "3",

}

TY - JOUR

T1 - Cardiolipin liposomes

T2 - A novel flow reagent for detection of anticardiolipin antibodies

AU - Pirruccello, Samuel Jay

AU - Brusnahan, S. K.

PY - 1990

Y1 - 1990

N2 - The association of autoantibodies with specificity for phospholipids and an increased risk for thromboembolic phenomena has received considerable recent clinical attention. These autoantibodies have been reported in patients with defined autoimmune disorders as well as in patients with no other obvious autoimmune disease symptoms other than isolated or recurrent thromboembolic disease. A significant component of this autoimmune response appears to be related to cardiolipin‐directed antibodies. Most studies reported to date have used either an enzyme immunoassay or a radioimmunoassay for detection and quantitation of antiphospholipid antibodies. We have developed a novel flow cytometric assay for detection of anticardiolipin antibodies. The assay, by analogy to polystyrene microsphere assay, utilizes cardiolipin liposomes as solid‐phase microspheres for antigen presentation. In comparison to enzyme‐linked immunosorbent assay, the flow assay shows similar sensitivity by serum titration, has immunoglobulin class specificity, and is semiquantitative as currently designed. The flow assay is relatively easy to perform and should allow detection of other antiphospholipid specificities with tailoring of the phospholipid makeup of the liposomes.

AB - The association of autoantibodies with specificity for phospholipids and an increased risk for thromboembolic phenomena has received considerable recent clinical attention. These autoantibodies have been reported in patients with defined autoimmune disorders as well as in patients with no other obvious autoimmune disease symptoms other than isolated or recurrent thromboembolic disease. A significant component of this autoimmune response appears to be related to cardiolipin‐directed antibodies. Most studies reported to date have used either an enzyme immunoassay or a radioimmunoassay for detection and quantitation of antiphospholipid antibodies. We have developed a novel flow cytometric assay for detection of anticardiolipin antibodies. The assay, by analogy to polystyrene microsphere assay, utilizes cardiolipin liposomes as solid‐phase microspheres for antigen presentation. In comparison to enzyme‐linked immunosorbent assay, the flow assay shows similar sensitivity by serum titration, has immunoglobulin class specificity, and is semiquantitative as currently designed. The flow assay is relatively easy to perform and should allow detection of other antiphospholipid specificities with tailoring of the phospholipid makeup of the liposomes.

KW - Systemic lupus erythematosus

KW - anticardiolipin antibodies

KW - flow cytometry

KW - thrombosis

UR - http://www.scopus.com/inward/record.url?scp=0025338330&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025338330&partnerID=8YFLogxK

U2 - 10.1002/jcla.1860040317

DO - 10.1002/jcla.1860040317

M3 - Article

C2 - 2191101

AN - SCOPUS:0025338330

VL - 4

SP - 236

EP - 240

JO - Journal of Clinical Laboratory Analysis

JF - Journal of Clinical Laboratory Analysis

SN - 0887-8013

IS - 3

ER -